Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2025-12-25 @ 4:41 PM
Study NCT ID:
NCT04564066
Status:
COMPLETED
Last Update Posted:
2021-04-05
First Post:
2020-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study to Compare the Safety and Effect of Efgartigimod as an Intravenous Infusion With the Effect of Efgartigimod as a Subcutaneous Injection in Healthy Volunteers
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-11
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-11
First Submit QC Date:
None
Study First Post Date:
2020-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-02
Last Update Post Date:
2021-04-05
Last Update Post Date Type:
ACTUAL